NTRA News

Latest breaking news and updates for NTRA stock.

Track all markets on TradingView

IMvigor011 Bladder Cancer Trial Achieves Positive Results, with Signateraā„¢ Strongly Predicting Adjuvant Immunotherapy Benefit

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced positive topline results from the randomized, phase III IMvigor...

How does this development position Natera relative to competitors in the circulating tumor DNA (ctDNA) testing market, and could it affect market share dynamics? What are the potential revenue implications for Natera from expanded Signateraā„¢ usage in bladder cancer and other oncology indications? How will the positive IMvigor011 trial results influence Natera's (NTRA) stock valuation in the short term?
Clinical trials
5 days ago
Read more businesswire

Natera Reports Second Quarter 2025 Financial Results

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today reported its financial results for the second quarter ended June 30, 2025...

Will the robust quarter trigger any notable insider buying or selling activity that could affect market perception? Is there any indication of changes in cash flow, capital allocation, or shareā€‘repurchase activity following the results? How does Natera's Q2 performance stack up against major competitors such as Illumina, Roche, and Guardant Health?
Earnings
16 days ago
Read more businesswire

Natera Launches Fetal Focusā„¢: A Noninvasive Prenatal Test for Inherited Conditions

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing and precision medicine, today announced the launch of Fetal Focus, a noninvasive prenat...

What are the potential risks if adoption rates of Fetal Focusā„¢ fall short of expectations? How might this product launch influence analyst sentiment and target price revisions for NTRA? Could the launch lead to partnerships or collaborations with obstetrics and fertility clinics, and how might that affect distribution costs?
Diagnostics
16 days ago
Read more businesswire